Lilly and Incyte Announce Submission of New Drug Application to FDA for Oral Once-Dai...
CNN Money,
INDIANAPOLIS, Jan. 19, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today…
INDIANAPOLIS, Jan. 19, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today…
INDIANAPOLIS, Jan. 19, 2016 /PRNewswire/ -- Eli Lilly and Company ( LLY ) and Incyte Corporation ( INCY ) today announced that…
INDIANAPOLIS, Jan. 19, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) and Incyte Corporation (NASDAQ: INCY ) today…
INDIANAPOLIS, Jan. 19, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today…
INDIANAPOLIS, Jan. 19, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today…
- Compared to methotrexate, baricitinib as monotherapy or in combination with methotrexate demonstrated improvements in all ACR…
-- Once-daily oral baricitinib significantly improved all seven components of ACR response versus injectable adalimumab -…
... INDIANAPOLIS Nov. 7 2015 /-...Lilly and Incyte previously announced that the study met its primary o...
-- Once-daily oral baricitinib significantly improved all seven components of ACR response versus injectable adalimumab -…
- Compared to methotrexate, baricitinib as monotherapy or in combination with methotrexate demonstrated improvements in all ACR…
... INDIANAPOLIS Nov. 4 2015 /- E... Lilly is committed to raising expectations for people living with som...Highlighted…
INDIANAPOLIS, Nov. 4, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announces that detailed data for two phase 3…
INDIANAPOLIS, Nov. 4, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announces that detailed data for two phase 3…
INDIANAPOLIS, Oct. 14, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today…
... INDIANAPOLIS Oct. 14 2015 /-
INDIANAPOLIS, Oct. 14, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today…
Baricitinib Demonstrates Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis in Pivotal Phase 3…
INDIANAPOLIS, Sept. 29, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today…
INDIANAPOLIS, Sept. 29, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today…
INDIANAPOLIS, Sept. 29, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today…
Eli Lilly and Company and Incyte Corporation have announced that five abstracts featuring data from three clinical studies and…
Eli Lilly and Company and Incyte Corporation have announced that five abstracts featuring data from three clinical studies and…